Risk factors associated with venous thromboembolism in breast cancer: a narrative review

Purpose To date, there is no universally acceptable risk assessment tool in clinical practice that accurately estimates the risk of venous thromboembolism (VTE) in patients with breast cancer, despite the large number of published studies. Thus, the aim of this narrative review was to summarize the...

Full description

Saved in:
Bibliographic Details
Published in:Supportive care in cancer 2022-10, Vol.30 (10), p.8589-8597
Main Authors: Razouki, Zayd Adnan, Ali, Nadeen T., Nguyen, Vinh Q., Escalante, Carmen P.
Format: Article
Language:English
Subjects:
Breast cancer
Cancer
Chemotherapy
Medical diagnosis
Medicine
Medicine & Public Health
Nursing
Nursing Research
Oncology
Oncology, Experimental
Pain Medicine
Patients
Pulmonary embolisms
Rehabilitation Medicine
Review Article
Risk assessment
Risk factors
Tamoxifen
Thromboembolism
Thrombosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To date, there is no universally acceptable risk assessment tool in clinical practice that accurately estimates the risk of venous thromboembolism (VTE) in patients with breast cancer, despite the large number of published studies. Thus, the aim of this narrative review was to summarize the most relevant risk factors for VTE in these patients. Methods We searched Ovid Embase and Ovid MEDLINE, from inception to March 26, 2021, to identify all articles that focused on breast cancer and multiple thromboembolic diseases. We also searched the references section of relevant articles to identify studies. We did not include case reports or case series with small sample size, N  
ISSN:0941-4355
1433-7339
DOI:10.1007/s00520-022-07045-y